Dec 29, 2022
From discussing “taking away the keys to the car” for a cognitively impaired older adult to decisions to limit life sustaining treatments at the end of life, conflict and disagreement permeate everything that we do in medicine. How well though are we taught to handle conflict and disagreement? I’d say not well...
Dec 15, 2022
We’ve talked at length on prior podcasts about the failures of aducnumab, Biogen, and the FDA’s decision to approve it.
But wait, there’s a shiny new anti-amyloid drug, lecanemab! (No it’s not just the French version of Aducanumab).
In an article in the NEJM (a published article this time, wonder...
Dec 8, 2022
Eric and I weren’t sure what to call this podcast - storytelling and medicine? Narrative medicine? We discussed it with today’s guests Heather Coats, palliative care NP-scientist, and Thor Ringler, poet. It wasn’t until the end that the best term emerged - storycatching. Because that really is what this...
Dec 2, 2022
What would it take to transform dementia care? While a lot of hope and money is being put into new monoclonal amyloid antibodies like lecanemab, the evidence is that while they are great in reducing amyloid in the brain for those with early Alzheimer’s disease, the effects are at best modest in slowing down the...
Nov 17, 2022
Assisted Living Communities (no longer preferable to call them Assisted Living Facilities, as we learned on the podcast) are…what, exactly? That’s the central question on today’s podcast. The problem is the tremendous heterogeneity in services offered and quality of care. If you’ve seen one Assisted Living...